LINC00424: A Drug Target / Disease Biomarker (G100874182)

Target Name: LINC00424

NCBI ID: G100874182

LINC00424

Other Name(s): Long intergenic non-protein coding RNA 424 | long intergenic non-protein coding RNA 424

LINC00424: A Drug Target / Disease Biomarker

LINC00424 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the LINC (long non-coding RNA) family of proteins, which have been identified as potential drug targets in a variety of diseases.

LINC00424 is involved in a variety of physiological processes in the body, including cell signaling, metabolism, and inflammation. It has been shown to play a role in the regulation of gene expression, and has been linked to the development and progression of a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key challenges in studying LINC00424 is its complexity as a protein. LINC00424 is a highly conserved protein that is expressed in a wide variety of organisms, making it difficult to study its function in a specific context. However, researchers have been able to use a variety of techniques to study its behavior, including biochemical, cellular, and computational studies.

One of the most promising aspects of LINC00424 is its potential as a drug target. LINC00424 has been shown to interact with a variety of molecules, including proteins and small molecules. These interactions make it a potential target for a variety of drugs, including inhibitors of protein synthesis, inhibitors of enzyme activity, and modulators of gene expression.

In addition to its potential as a drug target, LINC00424 is also a promising biomarker for a variety of diseases. Its expression has been shown to be altered in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, LINC00424 has been shown to be a reliable biomarker for tracking the effectiveness of certain treatments.

Overall, LINC00424 is a protein that has the potential to be a valuable drug target and biomarker for a variety of diseases. Further research is needed to fully understand its behavior and its potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 424

The "LINC00424 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00424 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets